Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Sciences (4)
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (2)
- Anatomy (2)
- Genetic Phenomena (2)
- Medical Pathology (2)
-
- Nursing (2)
- Cardiovascular System (1)
- Cell Biology (1)
- Cell and Developmental Biology (1)
- Chemicals and Drugs (1)
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)
- Dentistry (1)
- Diagnosis (1)
- Enzymes and Coenzymes (1)
- Hemic and Immune Systems (1)
- Immunology and Infectious Disease (1)
- Immunopathology (1)
- Life Sciences (1)
- Medical Anatomy (1)
- Medical Biotechnology (1)
- Medical Education (1)
- Oral and Maxillofacial Surgery (1)
- Surgical Procedures, Operative (1)
- Translational Medical Research (1)
- Institution
- Keyword
-
- AS1949490 (1)
- Acute Chest Syndrome (1)
- Adolescent (1)
- Anemia, Hemolytic, Congenital (1)
- Anemia, Sickle Cell (1)
-
- Angiogenesis (1)
- Ankyrins (1)
- Bilirubin (1)
- Bone Marrow (1)
- Cancer Survivorship (1)
- Child (1)
- Child, Preschool (1)
- Dental procedures (1)
- Endothelial Cell Biology (1)
- Female (1)
- Hematologic Malignancies (1)
- Hemoglobins (1)
- Hispanic Children; Rate of Relapse; Childhood Cancer Health Disparities; Thymic Stromal LymphoPoietin (1)
- Humans (1)
- INPPL1 (1)
- Lymphangiogenesis (1)
- Lymphatic System (1)
- Lymphedema (1)
- MAPK/ERK (1)
- Male (1)
- Near Infrared Fluorescence Imaging (1)
- Neutrophils (1)
- Next Generation Sequencing (1)
- PI3K/AKT (1)
- Postoperative Complications (1)
- Publication
- Publication Type
Articles 1 - 6 of 6
Full-Text Articles in Hemic and Lymphatic Diseases
Dental Extraction Is Probably Safe For Patients With Thrombocytopenia: The Standard Of Care Is A Guide For Clinical Decision Making Related To Platelet Transfusion., Phillip So
Clinical Research in Practice: The Journal of Team Hippocrates
A critical appraisal and clinical application of Fillmore WJ, Leavitt BD, Arce K. Dental extraction in the thrombocytopenic patient is safe and complications are easily managed. J Oral Maxillofac Surg. 2013 Oct;71(10):1647-1652. doi:10.1016/j.joms.2013.05.011.
Antithyroid Drug-Induced Agranulocytosis, Elizabeth Spears
Antithyroid Drug-Induced Agranulocytosis, Elizabeth Spears
Nursing Student Class Projects (Formerly MSN)
We live in a culture that is busy and constantly on the go. With little time to spare, often symptoms of an alteration in bodily function are pushed to the side and attribute to the stress of everyday life. With symptoms including nausea, fatigue, weight loss, nervousness, and irritability, one may be more inclined to disregard these symptoms, only to attribute them to effects of a busy lifestyle. The presentation of the previously listed symptoms can formulate a medical diagnosis of hyperthyroidism. According to the American Thyroid Association, 20 million Americans will develop some type of alteration in thyroid function …
Multiple Myeloma, Matthew Crowley
Multiple Myeloma, Matthew Crowley
Nursing Student Class Projects (Formerly MSN)
Multiple myeloma a rare and largely incurable malignant disease the affects the plasma cells. (Bilotti, Gleason, McNeill, and the International Myeloma Foundation Nurse Leadership Board, 2011). Understanding the pathophysiology of Multiple Myeloma (MM) and treatment options in Oncology and Hematology nursing can be difficult. It is the goal of this poster to outline the pathophysiology, prognosis, treatment options available to multiple myeloma patients. Multiple myeloma accounts for about 10% of hematologic malignancies in the U.S. (Kuo, Fenves, Mehta, 2011). MM is the second most common hematologic malignancy with twenty-four thousand new MM cases each year (Bianchi, and Anderson, 2014 )
Tslp-Induced Mechanisms And Potential Therapies For Crlf2 B-Cell Acute Lymphoblastic Leukemia, Olivia L. Francis
Tslp-Induced Mechanisms And Potential Therapies For Crlf2 B-Cell Acute Lymphoblastic Leukemia, Olivia L. Francis
Loma Linda University Electronic Theses, Dissertations & Projects
Childhood CRLF2 B-cell Acute Lymphoblastic Leukemia (CRLF2 B-ALL) is a high-risk form of leukemia that is associated with poor patient survival outcomes. CRLF2 B-ALL is five times more prevalent in Hispanic children than others and is associated with a higher rate of relapse, thus contributing significantly to childhood cancer health disparities. This disease occurs due to alterations of the CRLF2 gene, leading to overexpression of the CRLF2 protein- a component of the receptor signaling complex for the cytokine Thymic Stromal LymphoPoietin (TSLP) on the surface of B-ALL cells. TSLP has been shown to induce proliferation of human and mouse B-cell …
Src Homology 2 Domain-Containing 5’-Inositol Phosphatase-2 (Ship2) Is An Effector Of Lymphatic Dysfunction, Germaine D. Agollah
Src Homology 2 Domain-Containing 5’-Inositol Phosphatase-2 (Ship2) Is An Effector Of Lymphatic Dysfunction, Germaine D. Agollah
Dissertations and Theses (Open Access)
The lymphatic system is essential for the transport of excess fluid, protein, and foreign materials from interstitial tissues to lymph nodes; for immune surveillance, and to maintain fluid homeostasis. Dysregulated lymphatics can be attributed to pathological conditions including tumor metastasis, inflammation, chronic wounds, obesity, blood vascular disorders, and lymphedema. Of these, lymphedema is the most extreme of lymphatic disorders and is represented by a spectrum of symptoms ranging from mild, subtle presentation to severe, disfiguring, overt presentation. Lymphedema is more manageable in the early stages of disease but severely reduces quality of life with progression. Due to lack of molecular …
Clinical Outcomes Of Splenectomy In Children: Report Of The Splenectomy In Congenital Hemolytic Anemia Registry., Henry E. Rice, Brian R. Englum, Jennifer Rothman, Sarah Leonard, Audra Reiter, Courtney Thornburg, Mary Brindle, Nicola Wright, Matthew M. Heeney, Charles Smithers, Rebeccah L. Brown, Theodosia Kalfa, Jacob C. Langer, Michaela Cada, Keith T. Oldham, J Paul Scott, Shawn D. St Peter, Mukta Sharma, Andrew M. Davidoff, Kerri Nottage, Kathryn Bernabe, David B. Wilson, Sanjeev Dutta, Bertil Glader, Shelley E. Crary, Melvin S. Dassinger, Levette Dunbar, Saleem Islam, Manjusha Kumar, Fred Rescorla, Steve Bruch, Andrew Campbell, Mary Austin, Robert Sidonio, Martin L Blakely, Splenectomy In Congenital Hemolytic Anemia (Sicha) Consortium
Clinical Outcomes Of Splenectomy In Children: Report Of The Splenectomy In Congenital Hemolytic Anemia Registry., Henry E. Rice, Brian R. Englum, Jennifer Rothman, Sarah Leonard, Audra Reiter, Courtney Thornburg, Mary Brindle, Nicola Wright, Matthew M. Heeney, Charles Smithers, Rebeccah L. Brown, Theodosia Kalfa, Jacob C. Langer, Michaela Cada, Keith T. Oldham, J Paul Scott, Shawn D. St Peter, Mukta Sharma, Andrew M. Davidoff, Kerri Nottage, Kathryn Bernabe, David B. Wilson, Sanjeev Dutta, Bertil Glader, Shelley E. Crary, Melvin S. Dassinger, Levette Dunbar, Saleem Islam, Manjusha Kumar, Fred Rescorla, Steve Bruch, Andrew Campbell, Mary Austin, Robert Sidonio, Martin L Blakely, Splenectomy In Congenital Hemolytic Anemia (Sicha) Consortium
Manuscripts, Articles, Book Chapters and Other Papers
The outcomes of children with congenital hemolytic anemia (CHA) undergoing total splenectomy (TS) or partial splenectomy (PS) remain unclear. In this study, we collected data from 100 children with CHA who underwent TS or PS from 2005 to 2013 at 16 sites in the Splenectomy in Congenital Hemolytic Anemia (SICHA) consortium using a patient registry. We analyzed demographics and baseline clinical status, operative details, and outcomes at 4, 24, and 52 weeks after surgery. Results were summarized as hematologic outcomes, short-term adverse events (AEs) (≤30 days after surgery), and long-term AEs (31-365 days after surgery). For children with hereditary spherocytosis, …